BioSpace News Archive

MedX Health Corp. announced that it has signed an Exclusive Distribution Agreement with CBD Vida, to launch a comprehensive, ease-of-access skin scanning/assessment program throughout Brazil, using MedX’s DermSecureTM Telemedicine platform.

Kemin Industries, a global ingredient manufacturer focused on improving the quality of life for more than half the world’s population, recently showcased its new Aleta™ beta glucan to more than 60 veterinary specialists from the EMENA (Europe, Middle East, North Africa) and Southeast Asia regions at a seminar in Rome prior to the Intestinal Health Scientific Interest Group’s (IHSIG) 6th Conference on Poultry Intestinal Health in the city.

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (“CRH” or the “Company”), today announced the appointment of Dr. Tushar Ramani as CEO of the Company, replacing outgoing CEO Edward Wright.

ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced its release of VConnect, an automated data collection software module that enhances ValGenesis’ VLMS ability to automatically capture test results and process parameters from analytical instruments and manufacturing equipment, and directly plugs data into validation protocols, electronic batch records and equipment logs.

Full-service PR agency to sponsor healthcare event and co-present with medical robotics company on the ideal mix of paid, earned and owned media

Beth brings 17 years of extensive experience within the epilepsy field, which has been driven by her strong commitment to understanding the needs, aspirations and hopes of patients and their loved ones.

The court action is based on thorough legal and regulatory assessments and is made with a view of achieving final market approval of Brixadi™ weekly and monthly depot before 30 November 2020.

Treatment Center Hits Major Milestone for NY/NJ Tri-State area Cancer Community

- iSchemaView, the worldwide leader in advanced imaging for stroke, has received approval from AMAR (Israel’s Ministry of Health medical device regulation unit), for the use of the RAPID imaging platform across the State of Israel.

Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel anti-integrin therapies for the treatment of ocular diseases, today announced that two new independent members—Marc Carlson and Rebecca Colbert—have been appointed to the Company’s Board of Directors with Ms. Colbert serving as Chairperson of the Board’s Audit Committee.